<?xml version="1.0" encoding="Windows-31J"?>
<ArticleSet xmlns="http://www.openarchives.org/OAI/2.0/">
  <Article>
    <Journal>
      <PublisherName>MDPI</PublisherName>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn>1420-3049</Issn>
      <Volume>24</Volume>
      <Issue>11</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2019</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>Structural Modifications of Nature-Inspired Indoloquinolines: A Mini Review of Their Potential Antiproliferative Activity</ArticleTitle>
    <FirstPage LZero="delete"/>
    <LastPage/>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Ning</FirstName>
        <LastName>Wang</LastName>
        <Affiliation>Division of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University</Affiliation>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Marta</FirstName>
        <LastName>&#346;witalska</LastName>
        <Affiliation>Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences</Affiliation>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Li </FirstName>
        <LastName>Wang</LastName>
        <Affiliation>Division of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University</Affiliation>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Elkhabiry</FirstName>
        <LastName>Shaban</LastName>
        <Affiliation>Division of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University</Affiliation>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Md Imran</FirstName>
        <LastName>Hossain</LastName>
        <Affiliation>Division of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University</Affiliation>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Ibrahim El Tantawy </FirstName>
        <LastName>El Sayed</LastName>
        <Affiliation>Division of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University</Affiliation>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Joanna</FirstName>
        <LastName>Wietrzyk</LastName>
        <Affiliation>Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences</Affiliation>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Tsutomu</FirstName>
        <LastName>Inokuchi</LastName>
        <Affiliation>Division of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University</Affiliation>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>Cryptolepine, neocryptolepine and isocryptolepine are naturally occurring indoloquinoline alkaloids with various spectrum of biological properties. Structural modification is an extremely effective means to improve their bioactivities. This review enumerates several neocryptolepine and isocryptolepine analogues with potent antiproliferative activity against MV4-11 (leukemia), A549 (lung cancer), HCT116 (colon cancer) cell lines in vitro. Its activity towards normal mouse fibroblasts BALB/3T3 was also evaluated. Furthermore, structure activity relationships (SAR) are briefly discussed. The anticancer screening of neocryptolepine derivatives was performed in order to determine their cytotoxic and growth inhibitory activities across the JFCR39 cancer cell line panel. </Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">cryptolepine</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">neocryptolepine</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">isocryptolepine</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">antiproliferative activity</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">structure activity relationships</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
  <Article>
    <Journal>
      <PublisherName/>
      <JournalTitle>Acta Medica Okayama</JournalTitle>
      <Issn/>
      <Volume>60</Volume>
      <Issue>51</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2004</Year>
        <Month/>
      </PubDate>
    </Journal>
    <ArticleTitle>Reactivity of TEMPO anion as a nucleophile and its applications for selective transformations of haloalkanes or acyl halides to aldehydes</ArticleTitle>
    <FirstPage LZero="delete">11969</FirstPage>
    <LastPage>11975</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName EmptyYN="N">Tsutomu</FirstName>
        <LastName>Inokuchi</LastName>
        <Affiliation/>
      </Author>
      <Author>
        <FirstName EmptyYN="N">Hiroyuki</FirstName>
        <LastName>Kawafuchi</LastName>
        <Affiliation/>
      </Author>
    </AuthorList>
    <PublicationType/>
    <ArticleIdList>
      <ArticleId IdType="doi"/>
    </ArticleIdList>
    <Abstract>&lt;p&gt;Sodium 2,2,6,6-tetramethylpiperidine-N-oxide (TEMPO&amp;#8722;Na+), generated by reduction of TEMPO&#183; with sodium naphthalenide in THF, reacted with alkyl halides or acyl halides to produce O-alkylated or acylated TEMPOs, which were in turn oxidized with mCPBA or reduced with DIBAL-H to afford the corresponding aldehydes, thus accomplishing a new protocol for the halides-carbonyls conversion.&lt;/p&gt;
</Abstract>
    <CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">TEMPO and compounds</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Oxidation</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Reduction</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">mCPBA</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">DIBAL-H</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Aldehyde</Param>
      </Object>
    </ObjectList>
    <ReferenceList/>
  </Article>
</ArticleSet>
